4MR-17711-79625
3 vaccinations
3 coded responses
25 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 917 / CA
- Registered
- 2021-01-30
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-30
Registered in v-safe
-
2021-01-30
Dose 1 — Pfizer-BioNTech
- 2021-01-30
- 2021-01-31
-
2021-02-01
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Headache · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-05
- 2021-02-06
- 2021-02-13
-
2021-02-20
Dose 2 — Pfizer-BioNTech
-
2021-02-20
Survey response — day 0, dose 2MedDRA: Dizziness — Feeling: Poor · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: DizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-21
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness, Hot flush — Feeling: Fair · Site: Pain · HeadacheFree text: Dizziness, hot flashesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-22
- 2021-02-23
- 2021-02-24
- 2021-02-25
- 2021-02-26
- 2021-02-27
- 2021-03-06
- 2021-03-13
- 2021-03-20
- 2021-03-29
- 2021-04-05
- 2021-05-24
- 2021-08-23
-
2021-10-05
Dose 3 — Pfizer-BioNTech
-
2022-02-22
Survey response — 12 months, dose 2MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Got COVID in January 2022.MedDRA releases: 2024-11 · check-in free text available
-
2022-02-22
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-02-24
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-30 | Pfizer-BioNTech | |
| 2 | 2021-02-20 | Pfizer-BioNTech | |
| 3 | 2021-10-05 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-02-22 | Successful 2022-02-24 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 4 — day 0, dose 2
Systemic reaction (other): Dizziness
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Dizziness, hot flashes
Release 11 — 12 months, dose 2
Symptoms: Got COVID in January 2022.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Hot flush | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release